Correlation Between Energenesis Biomedical and Posiflex Technology

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Energenesis Biomedical and Posiflex Technology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Energenesis Biomedical and Posiflex Technology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Energenesis Biomedical Co and Posiflex Technology, you can compare the effects of market volatilities on Energenesis Biomedical and Posiflex Technology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Energenesis Biomedical with a short position of Posiflex Technology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Energenesis Biomedical and Posiflex Technology.

Diversification Opportunities for Energenesis Biomedical and Posiflex Technology

0.51
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Energenesis and Posiflex is 0.51. Overlapping area represents the amount of risk that can be diversified away by holding Energenesis Biomedical Co and Posiflex Technology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Posiflex Technology and Energenesis Biomedical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Energenesis Biomedical Co are associated (or correlated) with Posiflex Technology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Posiflex Technology has no effect on the direction of Energenesis Biomedical i.e., Energenesis Biomedical and Posiflex Technology go up and down completely randomly.

Pair Corralation between Energenesis Biomedical and Posiflex Technology

Assuming the 90 days trading horizon Energenesis Biomedical Co is expected to under-perform the Posiflex Technology. In addition to that, Energenesis Biomedical is 1.18 times more volatile than Posiflex Technology. It trades about -0.01 of its total potential returns per unit of risk. Posiflex Technology is currently generating about 0.12 per unit of volatility. If you would invest  11,050  in Posiflex Technology on September 14, 2024 and sell it today you would earn a total of  23,350  from holding Posiflex Technology or generate 211.31% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy79.54%
ValuesDaily Returns

Energenesis Biomedical Co  vs.  Posiflex Technology

 Performance 
       Timeline  
Energenesis Biomedical 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Energenesis Biomedical Co are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly stable basic indicators, Energenesis Biomedical is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.
Posiflex Technology 

Risk-Adjusted Performance

23 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in Posiflex Technology are ranked lower than 23 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal basic indicators, Posiflex Technology showed solid returns over the last few months and may actually be approaching a breakup point.

Energenesis Biomedical and Posiflex Technology Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Energenesis Biomedical and Posiflex Technology

The main advantage of trading using opposite Energenesis Biomedical and Posiflex Technology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Energenesis Biomedical position performs unexpectedly, Posiflex Technology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Posiflex Technology will offset losses from the drop in Posiflex Technology's long position.
The idea behind Energenesis Biomedical Co and Posiflex Technology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Other Complementary Tools

Fundamental Analysis
View fundamental data based on most recent published financial statements
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance